221 related articles for article (PubMed ID: 16188386)
1. Cystatin C and apoe polymorphisms in Italian Alzheimer's disease.
Nacmias B; Bagnoli S; Tedde A; Cellini E; Guarnieri BM; Bartoli A; Serio A; Piacentini S; Sorbi S
Neurosci Lett; 2006 Jan; 392(1-2):110-3. PubMed ID: 16188386
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity.
Nacmias B; Bagnoli S; Tedde A; Cellini E; Bessi V; Guarnieri B; Ortensi L; Piacentini S; Bracco L; Sorbi S
Arch Gerontol Geriatr; 2007; 45(2):201-6. PubMed ID: 17182125
[TBL] [Abstract][Full Text] [Related]
3. Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease.
Chuo LJ; Sheu WH; Pai MC; Kuo YM
Dement Geriatr Cogn Disord; 2007; 23(4):251-7. PubMed ID: 17310123
[TBL] [Abstract][Full Text] [Related]
4. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
[TBL] [Abstract][Full Text] [Related]
5. Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease.
Helisalmi S; Väkevä A; Hiltunen M; Soininen H
Dement Geriatr Cogn Disord; 2009; 27(4):318-21. PubMed ID: 19293566
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
[TBL] [Abstract][Full Text] [Related]
7. Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: a multicentric study.
Babiloni C; Benussi L; Binetti G; Bosco P; Busonero G; Cesaretti S; Dal Forno G; Del Percio C; Ferri R; Frisoni G; Ghidoni R; Rodriguez G; Squitti R; Rossini PM
Neuroimage; 2006 Feb; 29(3):948-64. PubMed ID: 16213753
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
[TBL] [Abstract][Full Text] [Related]
9. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
Cui T; Zhou X; Jin W; Zheng F; Cao X
Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
[TBL] [Abstract][Full Text] [Related]
10. Association analysis of the paraoxonase-1 gene with Alzheimer's disease.
Cellini E; Tedde A; Bagnoli S; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
Neurosci Lett; 2006 Nov; 408(3):199-202. PubMed ID: 16996683
[TBL] [Abstract][Full Text] [Related]
11. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
Bian JT; Zhang JW; Zhang ZX; Zhao HL
Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
[TBL] [Abstract][Full Text] [Related]
12. [An association analysis of apolipoprotein E genotypes with Alzheimer's disease in Chinese population].
Wu YN; Zhang JW; Zhang ZX; Qu QM; Chen D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):450-4. PubMed ID: 12905860
[TBL] [Abstract][Full Text] [Related]
13. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease.
Beyer K; Lao JI; Latorre P; Ariza A
Ann N Y Acad Sci; 2005 Dec; 1057():260-78. PubMed ID: 16399900
[TBL] [Abstract][Full Text] [Related]
14. [Analysis on association between the polymorphisms in apolipoprotein E, interleukin-1 alpha genes and Alzheimer's disease in Chengdu area].
Tang MN; Zhang ZX; Han HY; Liu XH; Shen Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):176-8. PubMed ID: 15079806
[TBL] [Abstract][Full Text] [Related]
15. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms.
Zappia M; Manna I; Serra P; Cittadella R; Andreoli V; La Russa A; Annesi F; Spadafora P; Romeo N; Nicoletti G; Messina D; Gambardella A; Quattrone A
Arch Neurol; 2004 Mar; 61(3):341-4. PubMed ID: 15023809
[TBL] [Abstract][Full Text] [Related]
16. No association between the cystatin C gene polymorphism and Alzheimer's disease: a case-control study in an Italian population.
Monastero R; Camarda C; Cefalù AB; Caldarella R; Camarda LK; Noto D; Averna MR; Camarda R
J Alzheimers Dis; 2005 Aug; 7(4):291-5. PubMed ID: 16131730
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E genotype in patients with Alzheimer's disease.
Luo B; Chen Z; Zhang Y; Pan X; Li X; Chen F
Chin Med J (Engl); 2003 Aug; 116(8):1220-2. PubMed ID: 12935416
[TBL] [Abstract][Full Text] [Related]
18. Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease.
Pritchard A; Harris J; Pritchard CW; St Clair D; Lemmon H; Lambert JC; Chartier-Harlin MC; Hayes A; Thaker U; Iwatsubo T; Mann DM; Lendon C
Neurosci Lett; 2005 Jul; 382(3):221-6. PubMed ID: 15925094
[TBL] [Abstract][Full Text] [Related]
19. Implication of GAB2 gene polymorphism in Italian patients with Alzheimer's disease.
Nacmias B; Tedde A; Bagnoli S; Cellini E; Guarnieri BM; Piacentini S; Sorbi S
J Alzheimers Dis; 2009; 16(3):513-5. PubMed ID: 19276544
[TBL] [Abstract][Full Text] [Related]
20. Short arm of chromosome 11 and sporadic Alzheimer's disease: catalase and cathepsin D gene polymorphisms.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Bifaro L; Menga R; Santamato A; Seripa D; Pilotto A; Capurso A; Panza F
Neurosci Lett; 2008 Feb; 432(3):237-42. PubMed ID: 18248894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
